AN2 Therapeutics, Inc. (NASDAQ:ANTX) IPO
IPO
Priced at US$15.00 a share on Mar 24, 2022.
- Price
- US$15.00 a share
- Shares offered
- 4,600,000 shares of common stock
- Offering size
- US$69 million
- Underwriters' option
- Up to 690,000 more shares
- Underwriters
- Cowen, SVB Leerink, Evercore ISI, Oppenheimer & Co. · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Sep 24, 2021 |
| Filed publicly | Mar 4, 2022 |
| Amended once | Mar 21, 2022 |
| Shares registered with an exchange | Mar 22, 2022 |
| Declared effective by the SEC | Mar 24, 2022 |
| Final prospectus, with the price | Mar 28, 2022 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 28, 2022 |
| EFFECT · Notice that a registration is effective | Mar 24, 2022 |
| S-1MEF · Registration of more shares for the same offering | Mar 24, 2022 |
| CERT · Exchange's certificate of listing | Mar 24, 2022 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 22, 2022 |
| CORRESP · Letter to the SEC | Mar 22, 2022 |
| CORRESP · Letter to the SEC | Mar 22, 2022 |
| S-1/A · Registration statement, amended | Mar 21, 2022 |
| S-1 · Registration statement | Mar 4, 2022 |
| DRSLTR · Letter to the SEC with a draft | Jan 19, 2022 |
| DRS/A · Draft registration statement, amended | Jan 19, 2022 |
| UPLOAD · Letter from the SEC | Dec 3, 2021 |
| DRS/A · Draft registration statement, amended | Nov 19, 2021 |
| DRSLTR · Letter to the SEC with a draft | Nov 18, 2021 |
| UPLOAD · Letter from the SEC | Oct 22, 2021 |
| DRS · Draft registration statement | Sep 24, 2021 |
From the cover of the final prospectus (424B4) filed Mar 28, 2022